Effect of lipoxygenase inhibitors and leukotriene antagonists on acute and chronic gastric haemorrhagic mucosal lesions in ulcer models in the rat

Journal of Gastroenterology and Hepatology (Australia)

Volumn 11, Issue 10, 1996, Pages 922-927

  Gyomber E ^a   Vattay, P ^a   Szabo, S ^a   Rainsford, K D ^b,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

gastritis; leukotrienes; mucosa; non steroidal anti inflammatory drugs; rat; ulcer

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; 4 [4 [3 (4 ACETYL 3 HYDROXY 2 PROPYLPHENOXY)PROPYLTHIO]PHENYL] 4 HYDROXY 3 METHYLBUTYRIC ACID; 7 CHLORO 4 HYDROXY 2 (4 METHOXYBENZYL) 3 METHYL 5 PROPYLBENZOFURAN; ACETYLSALICYLIC ACID; ALCOHOL; INDOMETACIN; IODOACETAMIDE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LIPOXYGENASE INHIBITOR; NORDIHYDROGUAIARETIC ACID; VERLUKAST;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; GASTRITIS; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; STOMACH HEMORRHAGE; STOMACH INJURY; ULCER;

EID: 0029816469     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1996.tb00274.x     Document Type: Article

References (35)

1. Szabo S, Trier JS, Brown A, Schnoor J. Early vascular injury and increased vascular permeability in gastric mucosal injury caused by ethanol in the rat. Gastroenterology 1985; 89: 228-36.
2. Guth PH. Vascular factors in gastric mucosal injury. In: Szabo S, Pfeiffer CJ, eds. Ulcer Disease: New Aspects of Parhogenesis and Pharmacology. Boca Raton: CRC Press, 1989; Ch. 11.
3. Robins PG. Ultrastructural observations of the pathogenesis of aspirin-induced acute gastric erosions. Br. J. Exp. Pathol. 1980; 61: 497-504.
4. Rainsford KD, Willis CM, Walker SA, Robins PG. Electron microscopic observations comparing the gastric mucosal damage induced in rats and pigs by benoxaprofen with aspirin, reflecting their differing actions as prostaglandin synthesis inhibitors. Br. J. Exp. Pathol. 1982; 63: 25-34.
5. Rainsford KD. Microvascular injury during gastric mucosal damage by anti-inflammatory drugs in pigs and rats. Agents Actions 1983; 13: 457-60.
6. Rainsford KD, Fox SA, Osborne DJ. Comparative effects of some non-steroidal anti-inflammatory drugs on the ultrastructural integrity and prostaglandin levels in the rat gastric mucosa: Relationship to drug uptake. Scand. J. Gastroenterol., 1984; 19 (Suppl. 101): 55-68.
7. Woods KL, Smith JL, Graham DY. Intragastric accumulation of Evan's blue as a method for assessing aspirin-induced acute gastric mucosal injury in humans. Dig. Dis. Sci. 1988; 33: 769-73.
8. Wallace JL, Keenan CM, Granger DN. Gastric ulceration induced by nonsteroidal anti-inflammatory drugs is a neutrophil-dependent process. Am. J. Physiol. 1990; 259: G462-7.
9. Rainsford KD. The effects of 5-lipoxygenase inhibitors and leukotriene antagonists on the development of gastric lesions induced by nonsteroidal antiinflammatory drugs in mice. Agents Actions, 1987; 21: 316-19.
10. 4 in rat gastric mucosa. Prostaglandins 1986; 31: 283-92.
11. 2α and thromboxane mimetic U-46619 on rat submucosal microcirculation in vivo. Am. J. Physiol. 1985; 248: G580-6.
12. 4 cause widespread and extensive plasma extravasation in the guinea pig. Naunyn-Schmiedeberg's Arch. Pharmacol. 1985; 330: 136-41.
13. Pihan G, Rogers C, Szabo S. Vascular injury in acute gastric mucosal damage. Mediatory role of leukotrienes. Dig. Dis. Sci. 1988; 33: 625-32.
14. Rogers C, Pihan G, Szabo S. Role for leukotrienes in the pathogenesis of haemorrhagic mucosal lesions induced by ethanol or HCl in the rat. Gastroenterology 1986; 90: 1797.
15. Belanger P, Maycock A, Guindon Y et al. L-656 224 (7-chloro-2-[(4-methoxyphenyl)methyl]-3-methyl-5-propyl-4-benzofuranol): A novel, selective, orally active 5-lipoxygenase inhibitor. Can. J. Physiol. Pharmacol. 1987; 65: 2441-8.
16. Jones TR, Young R, Champion E et al. L-649 923, Sodium (βS*, γR*)-4-(3-(4-acetyl-3-hydroxy-2-propylphenoxy) propylthio)-γ-hydroxy-β-methylbenzenebutanoate, a selective, orally active leukotriene receptor antagonist. Can. J. Physiol. Pharmacol. 1986; 64: 1068-75.
17. 4 receptor antagonist. Can. J. Physiol. Pharmacol. 1989; 67: 17-28.
18. Gillard JW, Dixon R, Ethiew D et al. Therapeutic potential of 5-lipoxygenase inhibitors: The discovery and development of MK886, a novel mechanism inhibitor. In: Rainsford KD, Velo GP, eds. Side Effects of Anti-inflammatory Drugs 3. Lancaster: Kluwer Academic Publishers, 1992; 275-86.
19. Guindon Y, Girard Y, Maycock A et al. L-651 392 a novel, potent and selective 5-lipoxygenase inhibitor. In: Samuelsson B et al., eds. Advances in Prostaglandins, Thromboxane and Leukotriene Research. New York: Raven Press, 1987; 554-7.
20. Salvati P, Whittle BJR. Investigation of the vascular actions of arachidonate lipoxygenase and cyclooxygenase products of the perfused stomach of rat and rabbit. Prostaglandins 1981; 22: 141-56.
21. Pendleton RG, Stavorski JR. Evidence for differing leukotriene receptors in gastric mucosa. Eur. J. Pharmacol. 1986; 125: 297-9.
22. 4 potentiate acid production by isolated rat parietal cells. Gastroenterology 1985; 97: 1420-9.
23. Wallace JL. Lipid mediators of inflammation in gastric ulcer. Am. J. Physiol. 1990; 258: G1-11.
24. Rogers C, Pihan G, Raza A, Szabo S. Possible participation of leukotrienes (LT) in the pathogenesis of gastric mucosal lesions and vascular injury induced by ethanol. HCl, NaOH, or aspirin (ASA) in the rat. Effect of eicosapentaenoic acid (EPA) or a lipoxygenase inhibitor, L-651 392. Gastroenterology 1987; 92: 1808.
25. Balaa MA, Goldgar DE. Lipoxygenase enzyme inhibitors diminish ethanol damage to the rat stomach. Clin. Res. 1986; 34: 436A.
26. Wallace FL, McKnight GW, MacNaughton WK. Effects of leukotrienes on susceptibility of the rat stomach to damage and investigation of the mechanism of action. Gastroenterology 1990; 8: 1178-86.
27. Walker JR, Harvey J. Actions of antiinflammatory drugs on leukotriene and prostaglandin metabolism: Relationships to asthma and other hypersensitivity reactions. In: Rainsford KD, Velo GP, eds. Side Effects of Anti-inflammatory/Analgesic Drugs. New York: Raven Press, 1984; 227-38.
28. Kuehl FA Jr, Dougherty HW, Ham EA. Interactions between prostaglandins and leukotrienes. Biochem. Pharmacol. 1984; 33: 105-16.
29. 4 and prostanoid release: Relation to ethanol induced injury. Br. J. Pharmacol. 1988; 93: 937-43.
30. Rainsford KD. Mechanisms of gastrointestinal ulceration from non-steroidal anti-inflammatory drugs: A basis for use and development of protective agents. In: Rainsford KD, Velo GP, eds. Side Effects of Anti-inflammatory Drugs 3. Lancaster: Kluwer Academic Publisher, 1992; 97-114.
31. Szabo S, Trier FS, Brown A, Schnoor F. Sulfhydryl blockers induce severe inflammatory gastritis in the rat. Gastroenterology 1984; 86: 1271.
32. Robert A, Everle D, Kaplowitz N. Role of glutathione in gastric mucosal cytoprotection. Am. J. Physiol. 1984; 247: G296-304.
33. Robert A, Nezamis JE, Lancaster C, Hanchar AJ. Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hyertonic NaCl, and thermal injury. Gastroenterology 1979; 77: 433-43.
34. Lacy ER, Ho S. Microscopic analysis of ethanol damage to rat gastric mucosa after treatment with a prostaglandin. Gastroenterology 1982; 83: 619-25.
35. Guth PH, Paulsen G, Nagata H. Histologic and microcirculatory changes in alcohol-induced gastric lesions in the rat: Effect of prostaglandin cytoprotection. Gastroenterology 1985; 87: 1083-90.